Yangzhou No.1 People's Hospital
8
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
13%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
Role: collaborator
To Improve the Rate of Mother's Own Milk Feeding of Premature Infants in NICU
Role: collaborator
Comparison of Detection and Miss Rates of Blue Laser Imaging Versus Conventional White Light Colonoscopy
Role: lead
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Role: collaborator
Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
Role: collaborator
Novel Risk Factors of Atrial Fibrillation in Patients With Chronic Heart Failure
Role: lead
Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Role: collaborator
Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia
Role: lead
All 8 trials loaded